
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-03-01-2017
- Volume 12
- Issue 3
Sartorius and the European Molecular Biology Laboratory Collaborate on Training
Sartorius and EMBL have entered into a corporate partnership program to foster advanced training.
Sartorius announced on Feb. 17, 2017 that it was partnering with the European Molecular Biology Laboratory (EMBL) research institute to advance scientific training and education. Sartorius will lend its expertise to EMBL’s Corporate Partnership Program, which fosters training collaboration to connect industry to academia.
The EMBL Corporate Partnership Program creates training courses, sponsors conferences, and organizes workshops at the institute’s International Center for Advanced Training. Sartorius will provide long-term support to EMBL’s education program by funding yearly travel bursaries for teachers who wish to attend EMBL’s Learning Laboratory for the Life Sciences classes.
“By focusing on professional training at all levels and ensuring that the next generation of young talent has access to the latest knowledge, we aim to support the scientific community to reach its maximum potential,” stated Karen Storm, vice-president of Marketing of the Lab Products & Services Division at Sartorius, in a press release.
Source: Sartorius
Articles in this issue
almost 9 years ago
Viewpoint: No Clear Path for Pharma or Outsourcingalmost 9 years ago
Standards Set Excipient GMPs, But Collaboration is Neededalmost 9 years ago
Mass Spectrometry Measures Up to Biologics Drug Analytical Challengesalmost 9 years ago
Monitoring Supply Chain Risk on a Limited Budgetalmost 9 years ago
Evaluating E&L Studies for Single-Use Systemsalmost 9 years ago
PfizerCentreOne Expands Fill/Finish Services in Michiganalmost 9 years ago
Metrohm USA Announces Winner of Young Chemist Awardalmost 9 years ago
Novasep Opens New Bioconjugation Unit in Francealmost 9 years ago
Kemwell Announces Successful FDA Inspection at Bangalore Facilityalmost 9 years ago
Abzena Signs Antibody Manufacturing Development Agreement with UCLNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.





